Finance

Lists
Why is THC down 2.86%?
Dive Deeper
THC:NYSE
Tenet Healthcare Corp
US$263.59
-2.86%
(-7.75) 1D
US$263.59
0.00% (0.00)
After hours
Closed: ኖቬም 19, 4:00:02 ከሰዓት ጂ ኤም ቲ-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for THC...
Open
US$270.23
High
US$271.89
Low
US$259.37
Mkt. cap
20.98 ቢ
Avg. vol.
840.64 ሺ
Volume
1.51 ሚ
P/E ratio
7.65
52-wk high
US$295.97
52-wk low
US$157.58
EPS
US$34.48
Beta
1.20
Shares outstanding
79.59 ሚ
No. of employees
88 ሺ
Open
US$270.23
High
US$271.89
Low
US$259.37
Mkt. cap
20.98 ቢ
Avg. vol.
840.64 ሺ
Volume
1.51 ሚ
P/E ratio
7.65
52-wk high
US$295.97
52-wk low
US$157.58
EPS
US$34.48
Beta
1.20
Shares outstanding
79.59 ሚ
No. of employees
88 ሺ
News stories
From web sources and news partners
Profile
Tenet Healthcare Corporation is an American for-profit multinational healthcare services company based in Dallas. Through its brands, subsidiaries, joint ventures, and partnerships including United Surgical Partners International, the company operates around 65 hospitals and over 450 healthcare facilities. Tenet also runs Conifer Health Solutions, which provides healthcare support services to health systems and other clients. Since its founding in 1969, Tenet has expanded significantly. Among other major acquisitions and formations, Tenet founded Conifer Health Solutions in 2008, MedPost Urgent Care in 2014, and in 2013 acquired Vanguard Health Systems, Inc., an investor-owned hospital company whose operations complemented Tenet's existing business. The acquisition created the third-largest investor-owned hospital company in the United States in terms of revenue and the third-largest in number of hospitals owned. In 2015, Tenet acquired USPI, which created the largest operator of outpatient surgery centers in the U.S. In 2021, the company ranked 167th in the Fortune 500. Wikipedia
About Tenet Healthcare Corp
CEOSaum Sutaria
Employees88.5 ሺ
Founded1969
Headquartersዳላስ, ቴክሳስ, ዩናይትድ ስቴትስ
SectorHealth Care
IndustryHealth care provider
Analyst ratings
Based on 16 analysts giving stock ratings to THC in the past 3 months
Strong buy
Buy
14
Hold
2
Sell
0
12-month forecast
Based on 16 Wall Street analysts offering 12 month price targets for THC in the last 3 months.
Highest
Current US$263.59
US$342.00 (+29.75%)
Average
US$308.27 (+16.95%)
Lowest
US$265.00 (+0.53%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ann Hynes
Mizuho Securities
Buy
Maintained
US$330.00
+25.2%
11/15/2026
Scott Fidel
Goldman Sachs
Buy
Maintained
US$320.00
+21.4%
11/10/2026
Kevin Fischbeck
Bank of America Securities
Buy
Maintained
-
-
11/05/2026
Andrew Mok CFA
Barclays
Buy
Maintained
US$297.00
+12.7%
11/04/2026
Matthew Gillmor CFA
KeyBanc
Buy
Maintained
US$300.00
+13.8%
11/03/2026
Whit Mayo
Leerink Partners
Buy
Reiterated
US$342.00
+29.7%
11/02/2026
A.J. Rice
UBS
Buy
Maintained
US$340.00
+29%
11/02/2026
Ben Hendrix
RBC Capital
Buy
Reiterated
US$304.00
+15.3%
11/01/2026
Ryan Langston
TD Cowen
Buy
Maintained
US$302.00
+14.6%
11/02/2026
Stephen Baxter
Wells Fargo
Buy
Maintained
US$321.00
+21.8%
11/02/2026
John Ransom
Raymond James
Buy
Maintained
US$300.00
+13.8%
10/30/2026
Craig Hettenbach
Morgan Stanley
Buy
Reiterated
US$297.00
+12.7%
10/30/2026
Sean Dodge
BMO Capital
Hold
Reiterated
US$265.00
+0.5%
10/29/2026
Jason Cassorla
Guggenheim
Buy
Maintained
US$306.00
+16.1%
10/29/2026
Michael Ha
Robert W. Baird
Hold
Maintained
US$285.00
+8.1%
10/30/2026
Andrew Cooper
Raymond James
Buy
Reiterated
US$285.00
+8.1%
09/28/2026
Benjamin Rossi
J.P. Morgan
Buy
Maintained
US$315.00
+19.5%
09/01/2026
Unknown Analyst
Stephens
Buy
Maintained
US$285.00
+8.1%
07/27/2026
Raj Kumar CFA
Stephens
Buy
Maintained
US$285.00
+8.1%
07/27/2026
David S Macdonald
Truist Financial
Buy
Reiterated
US$290.00
+10%
07/28/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
US$245.00
-7.1%
07/23/2026
Last report
29 ኦክቶ 2026
Fiscal period
Q3 2026
US$6.64 / US$4.68
+42.01%beat
Revenue / Est. (USD)
5.63 ቢ / 5.51 ቢ
+2.19%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ዲሴም 2025
ማርች 2026
ጁን 2026
ሴፕቴ 2026
Revenue
5.53 ቢ
5.37 ቢ
5.63 ቢ
5.63 ቢ
Cost of goods sold
3.23 ቢ
3.14 ቢ
3.22 ቢ
3.16 ቢ
Cost of revenue
3.23 ቢ
3.14 ቢ
3.22 ቢ
3.16 ቢ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
410.00 ሚ
102.00 ሚ
104.00 ሚ
105.00 ሚ
Operating expense
1.33 ቢ
1.27 ቢ
1.39 ቢ
1.40 ቢ
Total operating expenses
4.56 ቢ
4.40 ቢ
4.61 ቢ
4.56 ቢ
Operating income
965.00 ሚ
963.00 ሚ
1.02 ቢ
1.07 ቢ
Other non operating income
39.00 ሚ
43.00 ሚ
45.00 ሚ
39.00 ሚ
EBT including unusual items
681.00 ሚ
1.13 ቢ
1.34 ቢ
1.58 ቢ
EBT excluding unusual items
882.00 ሚ
852.00 ሚ
928.00 ሚ
972.00 ሚ
Income tax expense
37.00 ሚ
226.00 ሚ
295.00 ሚ
360.00 ሚ
Effective tax rate
5.43%
19.96%
22.01%
22.80%
Other operating expenses
687.00 ሚ
937.00 ሚ
1.07 ቢ
1.08 ቢ
Net income
371.00 ሚ
702.00 ሚ
826.00 ሚ
1.00 ቢ
Net profit margin
6.71%
13.08%
14.68%
17.76%
Earnings per share
4.70
4.82
6.12
6.64
Interest and investment income
-
-
-
-
Interest expense
-205.00 ሚ
-205.00 ሚ
-204.00 ሚ
-203.00 ሚ
Net interest expenses
-205.00 ሚ
-205.00 ሚ
-204.00 ሚ
-203.00 ሚ
Depreciation and amortization charges
231.00 ሚ
229.00 ሚ
215.00 ሚ
217.00 ሚ
EBITDA
1.20 ቢ
1.19 ቢ
1.24 ቢ
1.29 ቢ
Gain or loss from assets sale
5.00 ሚ
-1.00 ሚ
-33.00 ሚ
-9.00 ሚ
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google መተግበሪያዎች